An interventional study of Opioid Free Anesthesia (OFA) and Balanced anesthesia with opioids in Pain Management, sponsored by Jagiellonian University. Recruiting at 2 sites in Poland. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-04.
Sponsored by Jagiellonian University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 97 studies in Pain with a site in Poland — 9 open to participants now, 9 under way, none of them phase 3. Pain · Poland.
Among the 97 studies in Pain with a site in Poland, this one is the 44th largest by planned enrollment of the 89 interventional ones that give a count, is one of 4 that started in 2026, is one of 26 with no phase, and was the 94th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →9 of the 97 studies in Pain with a site in Poland are open now. Recruiting first, the newest first:
Teleflex · Sites in Poland, United States, France and 1 more country
Ages 18–80
Medical University of Silesia · Sites in Poland
Ages 18–75
Poznan University of Physical Education · Sites in Poland
Ages 18–90 · Healthy volunteers
KeyBioscience AG · Sites in Poland, Czechia, Denmark and 3 more countries
Ages 45+
Wroclaw Medical University · Sites in Poland
Ages 18–70 · Healthy volunteers
A study can be open while its sites in Poland have not opened yet or have stopped. Only those recruiting at a site in Poland →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
97 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 22 · Phase 3 37 · Phase 4 4
First in 2003; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 200 across the 89 interventional studies, 200 across the 7 observational. Of the 81 that completed or were terminated, 32 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
65 of 97 have an industry lead sponsor. The 10 most frequent:
Jagiellonian University is the lead sponsor of 161 studies on the registry; 34 are open to participants now.
Jagiellonian University has 6 studies filed under Pain — fewer than ten, so there is no comparison to draw.
5 of the studies in Pain with a site in Poland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06833749KeyBioscience AGEfficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis | 2026-11 |
| NCT04214561Wroclaw Medical UniversityRelationship Between Selected Parameters and Bruxism | 2026-12 |
| NCT06975345Wroclaw University of Health and Sport SciencesEffects of a Protocol of Hip Flexor Stretching on Chronic Mechanical, Non-specific LBP. | 2026-12-31 |
| NCT07434427Medical University of SilesiaComparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic Surgery | 2027-05 |
| NCT07831967Medical University of GdanskPerfusion Index Variability During Epidural Labor Analgesia | 2027-10-31 |
Add all 5 to your calendar (.ics) → With an account.
Among the 97 studies in Pain with a site in Poland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Opioid-free anesthesia is not associated with greater pain than opioid anesthesia and is associated with reduced postoperative pain.
In our study, the investigators would like to compare the measurement of total oxycodone consumption in the postoperative period in both groups and whether the use of opioid-free anesthesia would reduce opioid consumption by 30%. The secondary objective will be to assess pain in both groups during the first 48 postoperative hours in patients undergoing pancreatic surgery. Patients would be randomly assigned to anesthesia with and without opioids at 1, 2, 6, 12, 24, and 48 hours after surgery. Other secondary objectives include assessing the incidence of postoperative nausea and vomiting (PONV), adverse drug reactions, particularly cardiac arrhythmias, and the impact on persistent postoperative pain. On day 7 after surgery, each patient will receive the QOR-15 questionnaire to assess quality of life and the PQA-10 questionnaire.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who will have pancreatic operation under balanced anesthesia including opioids
Drug: Balanced anesthesia with opioids
Patients who willl have pancreatic operation under Opioid Free anesthesia
Other: Opioid Free Anesthesia (OFA)
Patients who will have pancreatic operation under Opioid Free anesthesia
Patients who will hav pancreatic operation under balanced anesthesia including opioids
Opioid consumption
measurement of total oxycodone consumption in the postoperative period
Time frame: up to 48 hours after surgery
Pain assessment
Assessment of pain at 1, 2, 6, 12, 24, and 48 hours after surgery by NRS scale (0-10, 0 - no pain, 10 worst pain imaginable)
Time frame: at 1, 2, 6, 12, 24, and 48 hours after surgery
PONV
assessment of the occurrence of postoperative nausea and vomiting (PONV)
Time frame: up to 48 h after surgery
Quality Of Recovery
QOR-15 questionnaire to assess quality of life and PQA-10 questionnaire. The QOR-15 is a 15 items questionnaire which provides a valid and efficient evaluation of the postoperative quality of recovery. The QoR 15 score is a score of 15 items, each scored from 0 to 10. These items assess 5 dimensions of post-operative recovery: pain, physical comfort, functional autonomy, emotions and psychological support. These 15 items represent the quality of post-operative rehabilitation in its physical and mental dimensions
Time frame: on the 7th day after surgery
Plan to share: Undecided — ndividual participant data (IPD) will be shared contingent upon obtaining appropriate consent from the study participants. Data will be made available only in accordance with applicable ethical and regulatory requirements.
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Dec 2027, 15 months after the start.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 15 months is above that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.